Comparative efficacy and safety of pharmacological treatments for lower-risk myelodysplastic syndromes: a Systematic Review and network meta-analysis - Poll - MDSpire

Comparative efficacy and safety of pharmacological treatments for lower-risk myelodysplastic syndromes: a Systematic Review and network meta-analysis

  • By

  • Haixia Zhang

  • Jiaqiang Hu

  • Yaxi Jiang

  • Lihua Deng

  • Song Liu

  • June 16, 2026

  • 0 min

Share

Original Source(s)

Comparative efficacy and safety of pharmacological treatments for lower-risk myelodysplastic syndromes: a Systematic Review and network meta-analysis

  • by Haixia Zhang, Jiaqiang Hu, Yaxi Jiang, Lihua Deng, Song Liu

  • June 16, 2026

Related Content

CRISPR Therapy Raises Fetal Hemoglobin in Sickle Cell Disease

An investigational Cas12a-edited stem cell treatment sharply boosted HbF and largely eliminated vaso-occlusive crises in an early trial

  • April 13, 2026

  • 2 min
A Family at War—Against Tropheryma whipplei: A Case Series

Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia